Stockreport

Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference

Sesen Bio, Inc.  (SESN) 
Last sesen bio, inc. earnings: 11/12 07:00 am Check Earnings Report
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--August 5, 2020 – Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the t [Read more]